Latest News

Ashburn, VA – October 23, 2018 – Established (founders of media company Tech.Co) has named Aperiomics the 2018 Startup of the Year for its innovation and the important work Aperiomics does to help people suffering from chronic infection. This award was given at the “Innovate Celebrate” competition in Boston on

Original article: https://technical.ly/dc/2018/09/28/aperiomics-takes-home-20000-grand-prize-at-2018-vinetta-project-final/ Four female founders presented at the final Vinetta Project pitch challenge in D.C. on Wednesday evening at Booz Allen Hamilton, where the #dctech community gathered to see who took home the $20,000 grand prize. Before the pitch competition kicked off, Vinetta Project CEO Vanessa Dawson shared some kind words, followed by a panel

Ashburn, VA – September 11, 2018 – Dr. Crystal Icenhour, CEO of Aperiomics and one of the fastest rising stars in American biotechnology, has been chosen to compete in the annual Vinetta Showcase in Washington, DC. Vinetta is a high-impact pitch and panel series in which top female founders of

Ashburn, VA – September 5, 2018 – Aperiomics named Startup of the Year's Top 100 Semifinalist for 2018! We will compete at the annual Innovate Celebrate conference in Boston this fall. Innovate Celebrate, co-hosted by Established (created by the founders of TechCo Media) and Consumer Technology Association (CTA) is the premiere

Ashburn, VA – March 13, 2018 – Aperiomics, a company that helps doctors and their patients worldwide solve difficult medical cases and limit the use of antibiotics, has again been named among the DC region’s most innovative companies. Aperiomics is a finalist in The Greater Washington Innovation Awards presented by

Presentation February 24 at UTPB J. Conrad Dunagan Library Odessa, TX, February 15, 2017 – Dr. Crystal Icenhour, born in Odessa, TX, is changing the way the medical industry thinks about fighing chronic infectious diseases with new methods of DNA analysis and will be a featured speaker Saturday, Febuary 24

Icenhour Presentation Wednesday, January 24, 8:00 a.m PST at the Computer Museum in Mountain View, CA Ashburn, VA –, January 19, 2017 – Dr. Crystal Icenhour, an expert in infectious disease diagnostics and a speaker at the upcoming Precision Medicine World Conference will present to attendees how Aperiomics is leading

Ashburn, VA – January 16, 2018 -- Aperiomics, the only company in the world that identifies every bacteria, virus, fungi and parasite in one test, today announced that Jiang Liu has joined the company as a bioinformatics scientist. Jiang joins the research and development team at Aperiomics after earning a

OriginalArticle: http://dc.citybizlist.com/article/455893/aperiomics-names-wynemah-fuller-operations-director Ashburn, VA , December 7, 2017 -- Aperiomics, a biotechnology company that harnesses the power of deep next-generation sequencing to identify all known pathogens (bacteria, virus, fungi or parasite) in a single test, today announced that Wynemah Fuller has joined the company as director of operations. Fuller

Original article: http://www.virginiabusiness.com/news/article/company-develops-single-test-to-identify-infectious-diseases Ashburn-based Aperiomics, a company that allows doctors to identify infectious diseases through a single test, says it has now received a total of $1.6 million from the National Science Foundation, as well as a $100,000 grant from Virginia’s Center for Innovative Technology. There’s an urgent need for Aperiomics’

Ashburn, VA, November 8, 2017 -- Aperiomics, a biotechnology company that harnesses the power of deep next-generation sequencing to identify all known pathogens (bacteria, virus, fungi or parasite) in a single test, today announced that it is partnering with Milenia Labs to further expand its international outreach. Milenia, based in

Ashburn, VA –, October 17, 2017 -- Aperiomics, a biotechnology company that saves lives by harnessing the power of deep next-generation sequencing to identify all known pathogens (bacteria, virus, fungi or parasite) in a single test, today announced the latest development in its growth. The company has closed a seed

Jason Zhang Ashburn, VA – August 28, 2017 -- Aperiomics, a biotechnology company that saves lives by harnessing the power of next-generation sequencing to identify any known pathogen (bacteria, virus, fungi or parasite) in a single test, today announced that Jian “Jason” Zhang has joined the company as

Ashburn, VA – August 8, 2017 -- Aperiomics, a biotechnology company that saves lives by harnessing the power of next-generation sequencing to identify any known pathogen (bacteria, virus, fungi or parasite) in a single test, today announced that Alvin (Yuan) Chen, PhD, has been named the company’s chief technology officer.

Original article: http://citybizlist.com/article/433201/biotechnology-company-aperiomics-launches-new-website Ashburn, VA – August 1, 2017 --Aperiomics, a biotechnology company that saves lives by harnessing next-generation sequencing to identify any known pathogen (bacteria, virus, fungi or parasite) in a single test to pinpoint the causes of infectious disease, today launched its new website – http://www.aperiomics.com -- an information portal for

Ashburn, VA – August 1, 2017 -- Aperiomics, a biotechnology company that saves lives by harnessing the power of next-generation sequencing to identify any known pathogen (bacteria, virus, fungi or parasite) in a single test, today announced that Robb Milne has joined the company as Director of Sales and Marketing.

Ashburn, VA – July 31, 2017 -- Aperiomics, a biotechnology company that saves lives by harnessing next-generation sequencing to identify any known pathogen (bacteria, virus, fungi or parasite) in a single test to pinpoint the causes of infectious disease, today launched its new website – http://www.aperiomics.com -- an information portal

Original article: https://cbi.gwu.edu/aperiomics-mentioned-technically-dc July 26, 2017 Aperiomics, a spin-off company from a joint venture between Professor Keith Crandall, Director of the Computational Biology Institute, and The George Washington University, was mentioned in "Technically DC" on June 28th, 2017. Their participation in DC I-Corps, a National Science Foundation-funded regional program sponsored by

Original article: https://www.vabio.org/news/news.asp?id=344198 Friday, May 5, 2017 Virginia Bio member, Aperiomics, a biotech company that has created a unique technology to revolutionize the diagnosis of infectious disease, has been selected to present at the Cavendish Global Health Impact Forum taking place May 7-9, 2017 in Washington, DC, co-hosted with the Virginia

Sterling, VA, May 5, 2017 – Aperiomics, a biotech company that has created a unique technology to revolutionize the diagnosis of infectious disease, announced today it has been selected to present at the upcoming Cavendish Global Health Impact Forum taking place May 7-9, 2017 in Washington, DC, co-hosted with the

Original article: http://www.clpmag.com/2017/05/aperiomics-brings-pathogen-testing-integrative-healthcare-field/ Ashburn, VA – May 2, 2017 -- Aperiomics recently introduced its infectious disease diagnostic services to the integrative healthcare field at the annual Integrative Healthcare Symposium in New York City. With a single test of any biological sample, Aperiomics seeks to accurately identify all microbes present—including pathogens—whether bacteria,

https://vimeo.com/200092539 Title: Use of Next-generation Sequencing for Pathogen Identification Technological advances in genomic sequencing are rapidly changing diagnostics. Learn how next-generation sequencing is being used to identify pathogens as never before. Dr. Crystal Icenhour, CEO of Aperiomics, will present technology that is able to identify over 1200 pathogens in

Original article: http://www.nature.com/webcasts/event/advances-in-precision-medicine-and-genomic-sequencing/ Next-generation sequencing platforms are opening up new opportunities in precision medicine by dramatically reducing the cost and time to access large volumes of genomic data. This webcast will highlight innovative technologies being developed by companies in the field, and how they are laying the groundwork for novel therapeutics

Original article: http://www.loudounsmallbiz.org/calendar/event-detail/2016/10/18/default-calendar/loudoun-tech-meetup-with-biotech-startup-aperiomics Join us for tech-minded conversation in a casual setting. Appetizers are on us- drinks are on you. This month we are excited to welcome Crystal Icenhour to lead a discussion on the emerging opportunities in the field of life sciences and bioscience in our region. This month Co-Founder

Original article: https://www.washingtonpost.com/news/on-small-business/wp/2016/09/14/business-rx-her-challenge-is-turning-a-service-into-a-product/?utm_term=.22e3dc06d630 By Special to The Washington Post September 14, 2016 This week, the leader of an Ashburn biotech start-up asks for advice on how to convert her diagnostic service into software that can be sold as a service. –Dan Beyers The entrepreneur Scientist Crystal Icenhour earned her PhD as

Original article: http://www.mlo-online.com/the-transformation-of-pathogen-diagnostics-through-next-generation-sequencing Dr. Crystal R Icenhour Clinical laboratories have multiple methods for diagnosing infectious disease, but the fact remains that despite culture, microscopy, antibody-based testing, and molecular testing such as PCR, up to 75 percent of infections are not diagnosed in a timely manner, if at all.1,2

Dr. Crystal R Icenhour Crystal Icenhour, PhD, has just become Board Chairman for VirginiaBio, the first woman in the organization’s 24-year history to hold this position. Dr. Icenhour has served on the 24-member Board since 2007 and as Vice Chairman for the past two years, focusing much of

MLO Aperiomics' Dr. Icenhour was recently profiled in Medical Laboratory Observer. Dr. Icenhour highlights next generation sequencing and how it can be paired with advanced data analysis for accurate pathogen identification. Aperiomics' unique data analytics are able to identify over 19,000 microbial species, which includes all sequenced pathogens. To read this

Innovation Awards Winner Aperiomics was selected from among five finalists as the Health & Life Sciences Innovator of the Year by the Northern Virginia Chamber of Commerce in their 2PndP Annual Greater Washington Innovation Awards. According to Northern Virginia Chamber President and CEO, Jim Corcoran, these award winners

Original article: http://www.innovatorsunder35.com/innovator/eduardo-castro Eduardo Castro 2016, Chile There isn´t a pathogen alive capable of eluding diagnosis, thanks to his software based on genetic sequencing Medicine Pinpointing the precise identity of the pathogen responsible for an illness can mark the difference between locating an effective cure and the patients finding themselves subjected

Lyme Disease Aperiomics is offering even non-scientists an opportunity to improve human health. The company has launched a crowdfunding campaign to support an adaptation of their technology to develop a faster and more accurate test for Lyme Disease than any currently available. Existing tests for this disease have

WIT Innovation Awards In a recent span of two weeks, Aperiomics has been named a finalist in two Greater Washington, DC, award competitions. The Northern Virginia Chamber of Commerce selected Aperiomics as a finalist in the Health & Life Sciences Innovator of the Year category for

Cory Strope Cory L. Strope, PhD, has joined Aperiomics as a new Bioinformatic Scientist in one of 50 positions nationwide that is funded through a special National Science Foundation initiative. The Small Business Postdoctoral Research Diversity Fellowship serves entrepreneurial companies who have received funding through the Phase II

Original article: https://www.genomeweb.com/informatics/aperiomics-resourcepath-partner-pathogen-testing?utm_source=TrendMD&utm_medium=TrendMD&utm_campaign=0 Dec 07, 2015 staff reporter NEW YORK (GenomeWeb) – Aperiomics and ResourcePath said today that they have entered into a strategic partnership to combine Aperiomics' data-analysis and bioinformatics technologies with ResourcePath's next-generation sequencing services for pathogen testing. The companies share space in Sterling, Virginia. ResourcePath, founded by

Dr. Alvin Yuan Chen Aperiomics has named Yuan Chen, PhD, as its new vice president of Research and Development. Dr. Chen is a Bioinformatics scientist with a strong interest in infectious disease. He received his PhD from the Chinese Academy of Science and recently completed a post-doctorate research

https://www.youtube.com/watch?v=Kc-3yLKgVBo National Science Foundation Published on Nov 8, 2015 Aperiomics, a small business funded by the National Science Foundation Small Business Innovation Research program, is developing a test that can identify a wide range of pathogens in one biological sample. Crystal Icenhour, CEO of Aperiomics, explains the technology

NSF SBIR Phase II Grant Brings Company’s NSF Awards Total to Nearly $1 Million Aperiomics has won its second award in a year through the National Science Foundation’s Small Business Innovation Research (SBIR) program. This new SBIR Phase II grant of nearly $737,000 follows earlier feasibility funding from

Original article: https://www.genomeweb.com/business-news/aperiomics-receives-follow-nsf-grant-develop-pathogen-id-platform?utm_source=TrendMD&utm_medium=TrendMD&utm_campaign=0 Jan 15, 2015 staff reporter NEW YORK (GenomeWeb) – Aperiomics has received a Phase 1B grant from the National Science Foundation's Small Business Innovation Research program to bring the company's current award total from the program to just under $180,000. According to the grant abstract, Aperiomics intends to "develop,

National Science Foundation Aperiomics has been awarded a Phase IB grant through the National Science Foundation’s Small Business Innovation Research (SBIR) program, bringing their current award total to nearly $180,000 from this program. The project, under the direction of Aperiomics Chief Science Officer Eduardo Castro-Nallar, PhD, is titled

Biotech Showcase Like swallows to Capistrano, investors interested in new opportunities in healthcare and life science sectors will be flocking to San Francisco in mid-January to discover fresh options at a cluster of related conferences where companies will present their investment needs during the 2015 JP Morgan Healthcare

Dr. Crystal Icenhour: Leader of The Science Advisory Board’s Next-Generation Sequencing Team Dr. Icenhour earned her Ph.D. in Pathobiology and Molecular Medicine from the University of Cincinnati Medical School of Graduate Studies in 2002. She went on to conduct postdoctoral research in the Thoracic Diseases Research Unit at the Mayo Clinic College

Aperiomics, founded in October 2013, is bringing ground-breaking solutions to market to address age-old life and death disease challenges. The company will introduce its breakthrough Absolute-NGS™ Pathogen Detection Platform to the Association for Molecular Pathology at the upcoming AMP 2014 Annual Meeting (Booth #1253) to be held November 12-15 near

Transformative Technology Offers Quick, Comprehensive Pathogen Detection Technology that can find a needle in a haystack is a great idea, but how about a technology that alerts you to the needle you didn’t know was lurking in the haystack? When the "needle" is a pathogen that causes illness in plants,